Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gap junction protein beta-2 (GJB2) is a member of the connexin family that forms gap junctions, enabling direct communication between adjacent cells. GJB2 is crucial for maintaining potassium ion levels and the function of cochlear cells in the inner ear, and it is also important for skin integrity. Mutations in GJB2 are a leading cause of non-syndromic autosomal recessive congenital hearing loss.
Forms intercellular channels allowing rapid exchange and homeostatic regulation via movement of ions and small molecules directly between cytoplasms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gap junction protein beta-2 (GJB2).